Global Meningococcal Group B Vaccine Market Outlook 2022
SKU ID :QYR-19652851 | Published Date: 06-Dec-2021 | No. of pages: 91Description
TOC
1 Meningococcal Group B Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Group B Vaccine
1.2 Meningococcal Group B Vaccine Segment by Type
1.2.1 Global Meningococcal Group B Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Meningococcal Group B Vaccine Segment by Application
1.3.1 Global Meningococcal Group B Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Public
1.3.3 Private
1.4 Global Meningococcal Group B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Group B Vaccine Revenue 2016-2027
1.4.2 Global Meningococcal Group B Vaccine Sales 2016-2027
1.4.3 Meningococcal Group B Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Meningococcal Group B Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Meningococcal Group B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Meningococcal Group B Vaccine Market Competitive Situation and Trends
2.5.1 Meningococcal Group B Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
2.5.3 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningococcal Group B Vaccine Retrospective Market Scenario by Region
3.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.3.1 North America Meningococcal Group B Vaccine Sales by Country
3.3.2 North America Meningococcal Group B Vaccine Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country
3.4.1 Europe Meningococcal Group B Vaccine Sales by Country
3.4.2 Europe Meningococcal Group B Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
3.5.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Meningococcal Group B Vaccine Sales by Country
3.6.2 Latin America Meningococcal Group B Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country
3.7.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Meningococcal Group B Vaccine Historic Market Analysis by Type
4.1 Global Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Meningococcal Group B Vaccine Price by Type (2016-2021)
5 Global Meningococcal Group B Vaccine Historic Market Analysis by Application
5.1 Global Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Meningococcal Group B Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Meningococcal Group B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Meningococcal Group B Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
7 Meningococcal Group B Vaccine Manufacturing Cost Analysis
7.1 Meningococcal Group B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meningococcal Group B Vaccine
7.4 Meningococcal Group B Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meningococcal Group B Vaccine Distributors List
8.3 Meningococcal Group B Vaccine Customers
9 Meningococcal Group B Vaccine Market Dynamics
9.1 Meningococcal Group B Vaccine Industry Trends
9.2 Meningococcal Group B Vaccine Growth Drivers
9.3 Meningococcal Group B Vaccine Market Challenges
9.4 Meningococcal Group B Vaccine Market Restraints
10 Global Market Forecast
10.1 Meningococcal Group B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Type (2022-2027)
10.2 Meningococcal Group B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Application (2022-2027)
10.3 Meningococcal Group B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Tables & Figures
List of Tables
Table 1. Global Meningococcal Group B Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Meningococcal Group B Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Meningococcal Group B Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Meningococcal Group B Vaccine Covered in This Study
Table 5. Global Meningococcal Group B Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Meningococcal Group B Vaccine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Meningococcal Group B Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Meningococcal Group B Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Group B Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Meningococcal Group B Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Meningococcal Group B Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Meningococcal Group B Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Meningococcal Group B Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2016-2021)
Table 43. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Meningococcal Group B Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Meningococcal Group B Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GSK Meningococcal Group B Vaccine Product
Table 52. GSK Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer Meningococcal Group B Vaccine Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Meningococcal Group B Vaccine Distributors List
Table 61. Meningococcal Group B Vaccine Customers List
Table 62. Meningococcal Group B Vaccine Market Trends
Table 63. Meningococcal Group B Vaccine Growth Drivers
Table 64. Meningococcal Group B Vaccine Market Challenges
Table 65. Meningococcal Group B Vaccine Market Restraints
Table 66. Global Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 67. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 68. Global Meningococcal Group B Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 69. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 70. Global Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 71. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Meningococcal Group B Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 75. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Meningococcal Group B Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meningococcal Group B Vaccine
Figure 2. Global Meningococcal Group B Vaccine Market Share by Type in 2020 & 2027
Figure 3. Bexsero Product Picture
Figure 4. Trumenba Product Picture
Figure 5. Other Product Picture
Figure 6. Global Meningococcal Group B Vaccine Market Share by Application in 2020 & 2027
Figure 7. Public
Figure 8. Private
Figure 9. Global Meningococcal Group B Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Meningococcal Group B Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Meningococcal Group B Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Meningococcal Group B Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Meningococcal Group B Vaccine Players: Market Share by Revenue in 2020
Figure 16. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global Meningococcal Group B Vaccine Sales Market Share by Region in 2020
Figure 19. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global Meningococcal Group B Vaccine Revenue Market Share by Region in 2020
Figure 21. the United States Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. UK Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Meningococcal Group B Vaccine by Type (2016-2021)
Figure 44. Sales Market Share of Meningococcal Group B Vaccine by Application (2016-2021)
Figure 45. Sales Market Share of Meningococcal Group B Vaccine by Application in 2020
Figure 46. Revenue Share of Meningococcal Group B Vaccine by Application (2016-2021)
Figure 47. Revenue Share of Meningococcal Group B Vaccine by Application in 2020
Figure 48. Manufacturing Cost Structure of Meningococcal Group B Vaccine
Figure 49. Manufacturing Process Analysis of Meningococcal Group B Vaccine
Figure 50. Meningococcal Group B Vaccine Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Companies
GSK
Pfizer
- PRICE
-
$2900$5800$4350Buy Now